Goldman Sachs
VTAK icon

Goldman Sachs’s Catheter Precision VTAK Stock Holding History

Goldman Sachs’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-703
Closed -$3.23K – 6677
2025
Q2 		$3.23K Buy
+703
New +$3.81K ﹤0.01% 6031
2023
Q1 		– Sell
-81
Closed -$91.2K – 6254
2022
Q4 		$91.2K Buy
+81
New +$67.1K ﹤0.01% 5501
2018
Q4 		– Hold
0
– -$359K – 5706
2018
Q3 		– Hold
0
– – – 4603

Other funds holding VTAK

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Goldman Sachs's VTAK Position: Q3 2025 in Review

Goldman Sachs sold out of Catheter Precision (VTAK) in Q3 2025, closing a stake of 703 shares — an estimated $3.23K sold.

Goldman Sachs first reported a position in VTAK in Q4 2022 and held it in 2 quarters. The position peaked at $91.2K in Q4 2022. 3 funds tracked by Wall St. Rank hold VTAK as of Q3 2025.

  • Goldman Sachs reported no remaining Catheter Precision position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 703 Catheter Precision shares in Q3 2025, an estimated $3.23K.
  • Goldman Sachs first reported a position in Catheter Precision in Q4 2022 and held it in 2 quarters.
  • Goldman Sachs's Catheter Precision position peaked at $91.2K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.